Sengenics applies the latest genomics technologies to identify the most comprehensive range of genetic disorders at a level of precision and accuracy previously considered improbable or too costly. Sengenics' current range of tests are based on microarrays designed by Oxford Gene Technoloy in conjuction with Emory Genetics, USA. It is the only microarray selected as the first-choice diagnostics for genetic disorders by the U.K. National Health Service and other leading medical institutions around the world. All of Sengenics' arrays are ISCA-approved.
Individuals & Families
Take a proactive role in your child's development and future health.
Knowing your child's genetic health risks early with objective certainty allows your doctor and you to better plan for
your child's development and
future wellbeing.
your child's development and
future wellbeing.
Medical Professionals
Now you can screen the whole genome to identify suspected syndromes with clear objective certainty.
The most accurate diagnostics tool is now available to help you pinpoint genetic disorders for early intervention. We also support you with informational and councelling resources from
around the world.
around the world.
Researchers
Use the very latest genomics and proteomics technologies to advance your research.
Leverage cutting-edge technologies
and expertise from Oxford to
enhance research and accelerate
Discovery.
and expertise from Oxford to
enhance research and accelerate
Discovery.
Sengenics is a member of The International Standards for Cytogenomic Arrays (ISCA) Consortium
+6 03 7877 6881